1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
about
The Use of 1α,25-Dihydroxyvitamin D₃ as an Anticancer AgentPerspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogsVitamin D and differentiation in cancer.Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapyAmelioration of central cardiovascular regulatory dysfunction by tropomyocin receptor kinase B in a mevinphos intoxication model of brain stem death.Inhibitors for the Vitamin D Receptor-Coregulator Interaction.Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistanceExpression of human kinase suppressor of Ras 2 (hKSR-2) gene in HL60 leukemia cells is directly upregulated by 1,25-dihydroxyvitamin D(3) and is required for optimal cell differentiationBeta-1 integrins mediate substrate dependent effects of 1alpha,25(OH)2D3 on osteoblasts.c-Jun N-terminal kinase 2 (JNK2) antagonizes the signaling of differentiation by JNK1 in human myeloid leukemia cells resistant to vitamin DVitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer.Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia.The role of phospholipase D in osteoblast response to titanium surface microstructure.Differentiation-inducing potency of the seco-steroid JK-1624F2-2 can be increased by combination with an antioxidant and a p38MAPK inhibitor which upregulates the JNK pathway.High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome.The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms.Ultraviolet A eye irradiation ameliorates colon carcinoma induced by azoxymethane and dextran sodium sulfate through β-endorphin and methionine-enkephalin.
P2860
Q26749030-831CC42F-C96B-4901-B4FF-545FE0B912D8Q26991440-167C8FB0-43CB-433E-8DA5-4C933FEFE598Q33646179-51D1684E-23CE-424C-95E2-4F3B6EC7FF6AQ33759350-6A9F7767-8C4E-4B4F-983C-AE50A561091AQ35635982-63DE7836-B477-4547-8A37-1F7241954850Q35909214-9BDE704A-5538-448C-BD89-282C5671960BQ35954885-3F2F45A4-FFB6-4B39-A306-4A612D14D424Q35958335-D326E2BF-3A67-47C7-B704-7C807EAE6E89Q37209794-F697A0C0-ACCA-4DB9-953D-8703225C9613Q37252079-9F688F1D-C3CF-4DCB-9C2A-A1A4D21FF9B8Q37400664-0D1A3E5A-1A22-47A2-B22C-5CB96613CD33Q37628136-F669259B-0A63-4103-BF3D-977BA2770521Q39808607-554AC87C-2024-4FAD-8D0C-9F882FD7B37EQ40116924-D05F4CFE-5E75-4F91-8A6E-E31325CCE686Q42285092-9AB0F035-C427-41F9-80DB-6C01B75A8DA9Q42416249-09972E68-ECA3-46A5-A2F5-F475FF14F96CQ48104644-61D0FCDA-F5F1-4808-9D77-8A1D42CBBA70
P2860
1Alpha,25-dihydroxyvitamin D3-mediated stimulation of steroid sulphatase activity in myeloid leukaemic cell lines requires VDRnuc-mediated activation of the RAS/RAF/ERK-MAP kinase signalling pathway.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
1Alpha,25-dihydroxyvitamin D3- ...... MAP kinase signalling pathway.
@en
type
label
1Alpha,25-dihydroxyvitamin D3- ...... MAP kinase signalling pathway.
@en
prefLabel
1Alpha,25-dihydroxyvitamin D3- ...... MAP kinase signalling pathway.
@en
P2860
P356
P1476
1Alpha,25-dihydroxyvitamin D3- ...... MAP kinase signalling pathway.
@en
P2093
Philip J Hughes
P2860
P304
P356
10.1002/JCB.20787
P577
2006-06-01T00:00:00Z